Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
AdaptHealth Corp. (NASDAQ: AHCO), a national leader in patient-centered healthcare-at-home solutions, has announced its participation in the Baird Global Healthcare Conference on September 10, 2024, in New York. The company will engage in a fireside chat at 12:15 PM ET.
AdaptHealth provides a comprehensive range of medical products and services, including sleep therapy equipment, diabetes management supplies, home medical equipment (HME), oxygen therapy, and other chronic care solutions. Serving patients across all 50 states through approximately 680 locations, AdaptHealth partners with diverse referral sources and caters to beneficiaries of Medicare, Medicaid, and commercial insurance, reaching about 4.1 million patients annually.
AdaptHealth Corp. (NASDAQ: AHCO) has appointed Scott Barnhart as Chief Operating Officer, effective September 23, 2024. Barnhart brings over 30 years of leadership experience in global operations, including supply chain management and logistics. He previously served as COO of Qurate Retail Group and held senior positions at Cardinal Health.
CEO Suzanne Foster stated that this change supports efforts to create clear roles, drive effective management, and align the organization's structure. The appointment aims to advance AdaptHealth's commitment to patient care and foster organic growth through operational excellence.
AdaptHealth is a national leader in healthcare-at-home solutions, serving approximately 4.2 million patients annually across all 50 states through 670 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) announced its participation in the Canaccord Genuity 44th Annual Growth Conference on August 14, 2024, in Boston. The company will present a fireside chat at 1:30 pm ET, with a webcast link available on its website under 'Investor Relations'.
AdaptHealth is a leading provider of patient-centered, healthcare-at-home solutions, including home medical equipment and supplies. Their offerings include sleep therapy equipment like CPAP and biPAP services, diabetes treatment devices such as continuous glucose monitors and insulin pumps, and various medical supplies for chronic conditions. They serve approximately 4.1 million patients annually across all 50 states with a network of roughly 680 locations in 47 states.
View the full press release on BusinessWire.
AdaptHealth Corp. (NASDAQ: AHCO) reported its Q2 2024 financial results, showing mixed performance. Net revenue increased by 1.6% to $806.0 million, while net income rose 39.0% to $19.4 million. However, Adjusted EBITDA decreased by 3.3% to $165.3 million. The company's cash flow from operations improved to $247.0 million year-to-date, with free cash flow reaching $77.9 million.
AdaptHealth updated its fiscal year 2024 guidance, adjusting net revenue to $3.255-$3.315 billion, maintaining Adjusted EBITDA at $660-$700 million, and increasing free cash flow to $160-$180 million. The company also announced plans to dispose of certain non-core assets in Q3 2024.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, has announced its second quarter 2024 earnings release date and conference call details. The company will release its financial results on Tuesday, August 6, 2024, before the financial markets open. A teleconference for analysts and investors will be held at 8:30 a.m. ET on the same day.
Interested parties can participate in the call by dialing (800) 343-4136 (Domestic) or (203) 518-9843 (International) and referencing Conference ID: AHCO2Q24. A webcast registration link is also provided. Following the live call, a replay will be available for six months on the company's website under the 'Investor Relations' section.
AdaptHealth Corp. (NASDAQ: AHCO) has announced significant changes to its board of directors and management. Dale Wolf has been appointed as Chair of the Board of Directors effective July 1, 2024, succeeding Richard Barasch. Dale Wolf has been a board member since November 2019. Additionally, CEO Suzanne Foster has joined the Board effective May 20, 2024. President Josh Parnes will step down from his role on August 31, 2024, and from the Board on December 31, 2024.
AdaptHealth specializes in providing home medical equipment, supplies, and related services, reaching approximately 4.1 million patients across the U.S. annually through its extensive network.
AdaptHealth Corp. (NASDAQ: AHCO) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024. AdaptHealth, a leader in providing patient-centered, healthcare-at-home solutions, will present at 9:20am ET. The company offers a comprehensive range of medical products and services, including sleep therapy equipment, diabetes treatment devices, home medical equipment, and chronic therapy services. AdaptHealth serves about 4.1 million patients annually through 680 locations in 47 states, partnering with a diverse network of referral sources like hospitals and clinics.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, announced its participation in the Jefferies Global Healthcare Conference in New York on June 5, 2024. The event will include a fireside chat at 4:00 pm ET, accessible via webcast on the company's website. AdaptHealth offers a comprehensive range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic condition management. The company serves around 4.1 million patients annually across all 50 states through a network of 680 locations in 47 states. Further details can be found on their investor relations page.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in the UBS Healthcare Services Cape Cod Summit on June 4, 2024. AdaptHealth provides a range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic therapy services. The company supports 4.1 million patients annually in all 50 states through a network of 680 locations in 47 states. AdaptHealth partners with a diverse network of referral sources such as hospitals, clinics, and skilled nursing facilities.
AdaptHealth Corp. (NASDAQ: AHCO) announced the grant of restricted stock units (RSUs) to Suzanne Foster, the newly appointed CEO, as an inducement under Nasdaq Listing Rule 5635(c)(4). The grant, approved by the Compensation Committee on May 11, 2024, covers 553,251 shares of common stock at target performance levels. The RSUs vest in three tranches: 229,740 shares over three years starting May 20, 2025, 93,771 shares over two years starting the same date, and the remaining shares based on the Total Shareholder Return (TSR) over a three-year period. The vesting depends on Ms. Foster's continued service with AdaptHealth. The company provides home medical equipment and services, reaching 4.1 million patients annually across 670 locations in 47 states.